SCHEMBL12726196

SCHEMBL12726196

COc1ccc(C(=O)Nc2ccc(-c3cn4cccc(C)c4n3)cc2)c(Oc2ccncc2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 5/20 0.55
▸ ALDH1A1 P00352 5/20 0.55
▸ MAPT P10636 5/20 0.55
▸ KMT2A Q03164 4/20 0.55
▸ HPGD P15428 2/20 0.55
▸ MEN1 O00255 3/20 0.50
▸ TP53 P04637 2/20 0.48
▸ HRH3 Q9Y5N1 2/20 0.48
▸ POLB P06746 2/20 0.47
▸ CYP3A4 P08684 1/20 0.45
▸ NPC1 O15118 5/20 0.45
▸ RAB9A P51151 5/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ NFKB1 P19838 2/20 0.45
▸ NFKB2 Q00653 2/20 0.45
▸ RELA Q04206 2/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ RECQL P46063 1/20 0.45
▸ RXFP1 Q9HBX9 2/20 0.45
▸ ESR1 P03372 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12726045 0.92 ALDH1A1 (0.52) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL15107970 0.88 MAPT (0.49) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL15107972 0.88 MAPT (0.53) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL13075437 0.87 MAPT (0.53) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL12726167 0.86 KDM4E (0.58) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL13075823 0.86 KDM4E (0.56) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL12726189 0.86 KDM4E (0.59) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL12726200 0.84 KDM4E (0.57) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL12726220 0.84 ALDH1A1 (0.57) KDM4EALDH1A1MAPTKMT2AHPGD
SCHEMBL12726060 0.84 ALDH1A1 (0.54) KDM4EALDH1A1MAPTKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8486936-B2 Antagonist of smoothened AllaChem, LLC (US) 2013-07-16 — — US disclosed
US-8486936-B2 Antagonist of smoothened AllaChem, LLC (US) 2013-07-16 — — US disclosed
US-20110098291-A1 ANTAGONIST OF SMOOTHENED Alla Chem Inc. (US) 2011-04-28 — — US disclosed
US-20110098291-A1 ANTAGONIST OF SMOOTHENED Alla Chem Inc. (US) 2011-04-28 — — US disclosed
WO-2010129620-A1 IMIDAZO [ 1, 2 -A] PYRIDIN-2 -YL-PHENYL DERIVATIVES TO BE USED IN CANCER TREATMENT ALLA CHEM, LLC (US) 2010-11-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110098291-A1 ANTAGONIST OF SMOOTHENED SMO, SHH, GLI1 KDM4E 1596/4885ALDH1A1 2639/4885MAPT 1534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback